Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024141 (
systemic lupus erythematosus
)
44,322
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Primary Gram-positive bacterial peritonitis developed in three patients with
systemic lupus erythematosus
(
SLE
). These cases suggest a possible association between these two entities. Furthermore, they emphasize the importance of accurate diagnosis when evaluating abdominal symptoms in patients with
SLE
.
JAMA
1975 Jun 02
PMID:Spontaneous peritonitis and systemic lupus erythematosus. Importance of accurate diagnosis of gram-positive bacterial infections. 23 51
A patient with
systemic lupus erythematosus
had chills, fever, and headache on four separate occasions after ibuprofen ingestion. One such episode was accompanied by cerebrospinal fluid findings compatible with meningitis. Drug rechallenge under controlled conditions established the relationship between ibuprofen ingestion and meningitis.
JAMA
1978 Mar 13
PMID:Ibuprofen-induced meningitis in systemic lupus erythematosus. 30 2
The safety and efficacy of influenza vaccination were studied in 32 healthy volunteers and in 62 patients with
systemic lupus erythematosus
(
SLE
), rheumatoid arthritis, degenerative joint disease, and other rheumatic diseases. These individuals, none of whom was acutely ill, were examined at the time of immunization and one week, three weeks, and four months later. Flare-ups of rheumatic disease following immunization were infrequent and usually minor. Seroconversion to A/New Jersey/76 developed in 62% to 87% of all individuals and to A/Victoria/75 in 62% to 69%. Antibody responses to A/New Jersey/76 were significantly lower in young patients taking glucocorticoids compared to those not taking glucocorticoids. The antibody responses to A/New Jersey/76 and A/Victoria/75 in patients with
SLE
were not different from normal responses. Administration of these vaccines was safe in these patients with stable disease and induced antibody responses in most individuals.
JAMA
1979 Jul 06
PMID:Influenza vaccination in patients with rheumatic diseases. Safety and efficacy. 31 49
Patients with
systemic lupus erythematosus
(
SLE
) and other connective tissue diseases were surveyed for the presence of antibodies to normal DNA, antibodies to a ribonuclease-insensitive acidic nuclear protein, and immune deposits in normal skin. While 80% of patients with
SLE
had abnormal values for at least two of these three tests, none of the patients with other connective tissue diseases had more than one abnormal value. The presence of RBC autoantibodies was found along with one of the other abnormal laboratory tests in 76% of patients with
SLE
, including 14% of patients not found to have two abnormal tests. None of the other patients tested had RBC autoantibodies. These findings suggest that a set of laboratory tests can be constructed as criteria for a diagnosis of
SLE
that would be as specific as the presently employed American Rheumatism Association criteria.
JAMA
1979 Sep 07
PMID:Laboratory criteria for a diagnosis of systemic lupus erythematosus. 31 5
Three young women with
systemic lupus erythematosus
who were given ibuprofen for arthritis voluntarily discontinued taking the drug. On reinstitution of therapy, profound hypotension, fever, and headaches developed within hours, without other identifiable cause. A possible relationship to salicylate intolerance was considered. Because of these apparent side effects, we stress caution in the use of ibuprofen in
systemic lupus erythematosus
, particularly if there is any history of salicylate intolerance.
JAMA
1979 Jun 15
PMID:Acute adverse reactions to ibuprofen in systemic lupus erythematosus. 43 58
Two patients with
systemic lupus erythematosus
had intermittent episodes of dysphagia associated with severe nonpleuritic chest pain. Esophageal manometry disclosed abnormalities characteristic of diffuse esophageal spasm. The findings suggest that diffuse spasm should be considered in the differential diagnosis of unexplained chest pain and dysphagia in patients with
lupus
.
JAMA
1979 Oct 26
PMID:Esophageal motor dysfunction in systemic lupus erythematosus. Two cases with unusual features. 48 Jun 25
Renal papillary necrosis occurred after fenoprofen calcium administration in a patient with
systemic lupus erythematosus
and urinary tract infection. Possible mechanisms of renal damage may be hypersensitivity, decreased blood flow, and decreased production of a prostaglandin E-like substance.
JAMA
1979 Oct 26
PMID:Renal papillary necrosis and pyelonephritis accompanying fenoprofen therapy. 48 29
Seventy-one children with the diagnosis of
systemic lupus erythematosus
(
SLE
) (39 cases), dermatomyositis (25 cases), or scleroderma (7 cases) were studied retrospectively. The children with
SLE
were much sicker than those with the other two diseases and were found to have a poorer prognosis than adults with
SLE
. In general, the earlier the age of onset, the poorer the prognosis. Early gastrointestinal bleeding, abnormal renal findings, and cardiac abnormalities heralded early death from
SLE
. The peak incidence of
SLE
near the time of puberty suggests hormonal influence on this disorder in children. Survival rates and morbidity improved as the treatment improved. Corticosteroids were the main therapeutic agents. The patients with scleroderma also received varying doses of vitamin E, penicillamine, chloroquine hydrochloride, and salicylates. The antimetabolites were used to treat
SLE
starting in the late 1960s.
JAMA
1977 Mar 14
PMID:Collagen disease in children. A review of 71 cases. 57 42
Myoglobin was detected in the sera of patients with dermatomyositis, polymyositis, scleroderma, and
systemic lupus erythematosus
(LE) with active myopathy. Overall, myoglobinemia was detected in 74.1% of sera taken from patients with active myositis before therapy, with slightly greater frequency in the groups with dermatomyositis and polymositis. With steroid therapy, this frequency fell to 43.4% and to 9.5% in patients in clinical remission not requiring therapy. Serum enzyme (creatine phosphokinase, lactic dehydrogenase, and SGOT) activity was higher in samples containing myoglobin, but there was considerable overlap between those with and without myoglobinemia. Sequential serum determinations in six patients demonstrated rapid reduction in the levels of serum myoglobin with therapy, usually before enzyme values had returned to normal. In one patient followed up for 30 months, myoglobinemia correlated with clinically observed exacerbations of rash and weakness to a greater degree than did enzyme determinations.
JAMA
1977 Apr 04
PMID:Myoglobinemia in inflammatory myopathies. 57 36
In a 12-year-old boy with clinical and histologic features of Mikulicz disease,
systemic lupus erythematosus
(
SLE
) developed two years later. Atrophic plaques and nodules in the skin along with substantial increase in salivary gland enlargement characterized the onset of
SLE
. There was lack of renal and joint manifestations, and no evidence of keratoconjunctivitis sicca or xerostomia was seen. Histopathologic changes in the skin lesions included mucinous infiltrates, chronic vasculitis, and dermal-epidermal junction findings typical of
SLE
. Direct immunofluorescene studies of skin lesions and normal-appearing skin showed granular deposition of immunoglobulins and complement at the dermal-epidermal junction zone. Level of anti-DNA antibodies was noticeably elevated, and the serum C3 value was depressed. The patient's response to systemic corticosteroid therapy was dramatic.
JAMA
1977 Jun 06
PMID:Mikulicz disease and subsequent lupus erythematosus development. 57 64
1
2
3
4
Next >>